Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates.
Newton
D
D
VAMC, Memphis, Tennessee, USA.
Norrby-Teglund
A
A
McGeer
A
A
Low
D E
DE
Schlievert
P M
PM
Kotb
M
M
D001426:Bacterial Proteins; D004196:Disease Outbreaks; D005098:Exotoxins / Q000235:genetics; D005798:Genes, Bacterial; D006801:Humans; D008565:Membrane Proteins; D009864:Ontario / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D012703:Serotyping; D012772:Shock, Septic / Q000453:epidemiology / Q000382:microbiology*; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000145:classification / Q000235:genetics / Q000276:immunology*; D018089:Superantigens / Q000096:biosynthesis / Q000302:isolation & purification*
D001426:Bacterial Proteins; D005098:Exotoxins; D008565:Membrane Proteins; C117980:SpeA protein, Streptococcus pyogenes; D018089:Superantigens; C027951:erythrogenic toxin